Literature DB >> 15036003

Exposure to beta-carbolines norharman and harman.

W Pfau1, K Skog.   

Abstract

The aromatic beta-carbolines norharman and harman have been implicated in a number of human diseases including Parkinson's disease, tremor, addiction and cancer. It has been shown that these compounds are normal body constituents formed endogenously but external sources have been identified. Here, we summarise literature data on levels of norharman and harman in fried meat and fish, meat extracts, alcoholic drinks, and coffee brews. Other sources include edible and medicinal plants but tobacco smoke has been identified as a major source. Exposure levels from these different dietary sources are estimated to a maximum of 4 microg norharman per kg body weight (bw) per day and 1 microg harman per kg bw per day. Exposure via tobacco smoke depends on smoking habits and type of cigarettes but can be estimated to 1.1 microg/kg bw for norharman and 0.6 microg/kg bw for harman per package of cigarettes smoked. Studies on toxicokinetics indicate that inhalative exposure leads to a rapid increase in plasma levels and high bioavailability of norharman and harman. Oral bioavailability is lower but there are indications that sublingual absorption may increase dietary uptake of beta-carbolines. Endogenous formation can be estimated to be 50-100 ng/kg bw per day for norharman and about 20 ng/kg bw per day for harman but these rates may increase with high intake of precursors. Biomarker studies on plasma levels of beta-carbolines reported on elevated levels of norharman, harman or both in diseased patients, alcoholics and following tobacco smoking or consumption of beta-carboline-containing food. Cigarette smoking has been identified as major influence but dietary exposure may contribute to exposure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036003     DOI: 10.1016/j.jchromb.2003.10.044

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  45 in total

1.  Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive.

Authors:  Young-Gyun Park; Hye-Yeon Park; C Justin Lee; Soonwook Choi; Seonmi Jo; Hansol Choi; Yang-Hann Kim; Hee-Sup Shin; Rodolfo R Llinas; Daesoo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

2.  A spectroscopic study of the interaction of the fluorescent beta-carboline-3-carboxylic acid N-methylamide with DNA constituents: nucleobases, nucleosides and nucleotides.

Authors:  Iñigo X García-Zubiri; Hugh D Burrows; Joao S Seixas de Melo; María Monteserín; Antonio Arroyo; María J Tapia
Journal:  J Fluoresc       Date:  2008-05-11       Impact factor: 2.217

3.  Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models.

Authors:  Mrittika Chattopadhyay; Anindya Roy Chowdhury; Ting Feng; Charles-Antoine Assenmacher; Enrico Radaelli; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2019-05-20       Impact factor: 5.157

4.  Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.

Authors:  David J Wagner; Haichuan Duan; Alenka Chapron; Richard W Lee; Joanne Wang
Journal:  Xenobiotica       Date:  2017-03-02       Impact factor: 1.908

5.  Blood harmane concentrations and dietary protein consumption in essential tremor.

Authors:  E D Louis; W Zheng; L Applegate; L Shi; P Factor-Litvak
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

6.  Behavioural studies on the ethanol leaf extract of Grewia carpinifolia in Wistar rats.

Authors:  Olamide E Adebiyi; Funmilayo E Olopade; James O Olopade; Funsho O Olayemi
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

7.  Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin.

Authors:  Dea Shahinas; Gregory Macmullin; Christan Benedict; Ian Crandall; Dylan R Pillai
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

Review 8.  Dietary inhibitors of monoamine oxidase A.

Authors:  Sarah E Dixon Clarke; Rona R Ramsay
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

9.  Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in dystonia cases vs. controls.

Authors:  Elan D Louis; Pam Factor-Litvak; Monika Michalec; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2014-06-23       Impact factor: 4.294

10.  Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness.

Authors:  Elan D Louis; Wei Zheng; Wendy Jiang; Kenneth T Bogen; Garrett A Keating
Journal:  J Toxicol Environ Health A       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.